Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Five-year follow-up from the small, randomized REVELATION trial indicates that rates of clinical events are similar between STEMI patients initially randomized to a drug-coated balloon (DCB) or ...
WASHINGTON, DC—A newly approved drug-coated balloon (DCB) for the treatment of in-stent restenosis (ISR) continues to be safe and effective, with fewer events and repeat interventions compared with ...
Please provide your email address to receive an email when new articles are posted on . The FDA’s Circulatory System Devices Panel voted not to recommend approval of a drug-coated balloon to treat ...
As a small-cap finance stock with a market capitalisation of ₹67b, the risk and profitability of DCB Bank Limited (NSE:DCBBANK) are largely tied to the underlying economic growth of the region it ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — A new study supports the safety and effectiveness of the Chocolate Touch drug-coated balloon for ...
Simultaneously, DCB Bank has also posted its financial results for the fourth quarter ended on March 31, 2024. The company's profit increased by 9.5 per cent to Rs 155.68 crore in comparison with last ...
Among the lenders in the private sector, DCB Bank has announced an interest rate hike on fixed deposits under ₹2 crore. According to the bank's official website, the new rates come into operation on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results